Gastroenterology – Medxy AI

Sex-Based Disparities in Surgical Opportunities During Early Adoption of Robot-Assisted Surgery

By MedXY 08/06/2026

This study reveals significant sex-based disparities in access to robot-assisted surgery operative experience, showing female surgeons perform fewer robot-assisted procedures than males, potentially impacting career progression.

Gastroenterology Infectious Diseases news

Enhancing Hepatitis B Treatment: Pegylated Interferon After Nucleos(t)ide Withdrawal Boosts HBsAg Loss in HBeAg-Negative Patients

By MedXY 08/06/2026

Adjuvant pegylated interferon following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B significantly increases HBsAg loss rates and reduces severe hepatic flares over three years compared to withdrawal alone.

Gastroenterology news

Subtype-Specific Enteric Neuronal Activation in IBS: Linking Faecal Proteases and Immune Signatures

By MedXY 08/06/2026

This study elucidates how faecal proteases and immune proteins distinctly activate enteric neurons in IBS subtypes, revealing subtype-specific pathological mechanisms and potential diagnostic biomarkers, highlighting novel therapeutic targets for IBS management.

Gastroenterology news

Liver Stiffness Measurements as Prognostic Tools in Primary Sclerosing Cholangitis: Insights from the Prospective FICUS Cohort

By MedXY 08/06/2026

This prospective study confirms that liver stiffness measurements by Fibroscan® strongly predict transplant-free survival in primary sclerosing cholangitis patients, validating both static values and dynamic changes as vital prognostic markers.

Diabetes & Endocrinology Gastroenterology news

Disentangling Weight Loss-Dependent and Independent Effects of Survodutide on Liver Outcomes in MASH: Insights from a Phase 2 Mediation Analysis

By MedXY 08/04/2026

This mediation analysis of a phase 2 MASH trial reveals that survodutide improves liver inflammation and fibrosis predominantly through weight-independent mechanisms, highlighting a potential direct hepatic effect beyond weight reduction.

Gastroenterology Internal Medicine news

Rapid Skeletal Muscle Loss in Cirrhosis: Predictors, Outcomes, and Implications for Clinical Management

By MedXY 08/04/2026

Rapid skeletal muscle loss occurs in a significant subset of cirrhosis patients and independently predicts waitlist mortality, highlighting sarcopenia as a critical therapeutic target in liver disease management.

Clinical Updates Gastroenterology news

Acute Colonic Ischemia Following Elective Colectomy for Cancer: Risk Factors, Procedural Associations, and Outcomes

By MedXY 08/02/2026

Postoperative colonic ischemia is a rare but severe complication after colectomy for colorectal cancer, primarily linked to specific resection types and vascular comorbidities, significantly impacting patient morbidity and mortality.

Gastroenterology news Oncology

RIPPLY1 as a Guardian Against Cancer Stemness in CTNNB1-Mutated Hepatocellular Carcinoma

By MedXY 07/31/2026

RIPPLY1 suppresses cancer stemness by targeting TBX19, improving prognosis in CTNNB1-mutated hepatocellular carcinoma through inhibition of tumor progression.

Diabetes & Endocrinology Gastroenterology news

Proteomic Insights into MASLD: Sex-Specific Endotypes and Predictive Value for Mortality

By MedXY 07/31/2026

A large-scale proteomic study identified distinct MASLD subtypes influenced by sex differences and developed a four-protein score predicting all-cause mortality, advancing personalized risk assessment beyond traditional liver-centric models.

Gastroenterology news Oncology

Revolutionizing Stage II Colorectal Cancer Prognostication: Validating Semantically-Enhanced AI for Risk Stratification

By MedXY 07/31/2026

A novel AI model, SÉMIL, integrating vision-language and multiple instance learning, improves prognostic accuracy for stage II colorectal cancer by refining risk stratification beyond current clinical assessments, especially within NCCN high-risk subgroups.

Gastroenterology news Oncology

Improved Survival in Unresectable Hepatocellular Carcinoma with Combined Transarterial Chemoembolization and Thermal Ablation: Insights from the Phase 3 TORCH Trial

By MedXY 07/30/2026

The phase 3 TORCH trial demonstrates that adding selective radiofrequency ablation after transarterial chemoembolization significantly improves progression-free and overall survival in patients with unresectable liver-confined hepatocellular carcinoma, with acceptable safety.

Gastroenterology news Oncology

Comparing FLOT and CROSS Protocols: Survival and Recurrence in Esophageal Adenocarcinoma with Pathological Complete Response

By MedXY 07/24/2026

This cohort study compares long-term survival and recurrence in esophageal adenocarcinoma patients achieving pathological complete response (pCR) after neoadjuvant FLOT chemotherapy versus CROSS chemoradiotherapy, highlighting better outcomes with FLOT.

Gastroenterology news

Endothelial-to-Mesenchymal Transition: Unlocking New Therapeutic Avenues for Portal Vein Thrombosis in Cirrhosis

By Zhang Paul 07/23/2026

Highlight Portal vein thrombosis (PVT) in cirrhosis involves unique structural and cellular changes, including eccentric…

Gastroenterology news

International Consensus on Measuring and Repairing the Gut Barrier in IBD: Practical guidance for clinical trials

By Zhang Paul 07/23/2026

Introduction Inflammatory bowel diseases (IBD)—ulcerative colitis (UC) and Crohn’s disease (CD)—are characterized by chronic intestinal…

Gastroenterology news Oncology

Targeting the IL-17/NGAL/NETs/ITGA5 Axis: A Novel Strategy to Overcome Immunosuppression and Fibroblast Reprogramming in Pancreatic Cancer

By MedXY 07/20/2026

This study unravels how tumour-derived NGAL induces NETs that reprogram fibroblast subtypes via ITGA5, promoting immunosuppression and tumour progression in pancreatic ductal adenocarcinoma, suggesting combinatorial therapies to enhance immunotherapy efficacy.

Gastroenterology news Oncology

DR5/Ligase 3 Feedback Loop: Unlocking the Immunogenicity of Mismatch Repair-Deficient Colorectal Cancer

By MedXY 07/20/2026

This study uncovers a novel DR5/Ligase 3 feedback mechanism that sustains immunogenicity and enhances immune checkpoint inhibitor response in mismatch repair-deficient colorectal cancer.

Clinical Updates Gastroenterology Infectious Diseases news

Hepatitis C Screening Among Persons Experiencing Homelessness in Emergency Departments: Insights from the DETECT Hep C Screening Trial and Related Evidence

By MedXY 07/17/2026

Emergency departments serve as vital venues for hepatitis C virus screening, particularly for persons experiencing homelessness who exhibit higher HCV prevalence and face healthcare access barriers. Evidence supports nontargeted screening in EDs to improve detection and engagement in this vulnerable population.

Gastroenterology Infectious Diseases news

Unraveling the Diarrheal Outbreaks: Understanding Cyclospora and Cryptosporidiosis in the United States

By MedXY 07/17/2026

This article explores recent outbreaks of Cyclospora and Cryptosporidium infections in the U.S., their transmission, clinical features, diagnosis, treatment, and prevention, highlighting the public health impact and clinical challenges.

Gastroenterology Internal Medicine news

Polypharmacy Challenges in Older Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease: Navigating Care in a High-Risk Population

By MedXY 07/17/2026

Older adults with MASLD, especially those aged 75 and above, experience a high burden of polypharmacy linked to multimorbidity, necessitating careful medication management to balance disease control and geriatric vulnerabilities.

Gastroenterology General Surgery news

Timing Matters: Optimizing Additional Surgery after Noncurative Endoscopic Submucosal Dissection in Early Gastric Cancer

By MedXY 07/17/2026

Delaying additional surgery beyond 35 days after noncurative endoscopic submucosal dissection (ESD) in early gastric cancer reduces operative time and blood loss, potentially improving perioperative outcomes.